InsiderClue
Insiders · Profile

Eydelman Mikhail

SVP, GEN COUNSEL & CORP SEC at Vaxcyte. Filing since 2 Oct 2023. CIK 0001918033

Company
Date
Role
Action
Shares
Amount
Of holding
PCVX Vaxcyte, Inc.
5 Mar 2025
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,000
$353.70K
10.7%
PCVX Vaxcyte, Inc.
5 Feb 2025
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,000
$450.37K
15.1%
PCVX Vaxcyte, Inc.
6 Jan 2025
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,000
$427.92K
15.1%
PCVX Vaxcyte, Inc.
5 Dec 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,000
$457.43K
14.8%
PCVX Vaxcyte, Inc.
5 Nov 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,000
$531.80K
14.9%
PCVX Vaxcyte, Inc.
7 Oct 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,000
$546.35K
14.9%
PCVX Vaxcyte, Inc.
1 Oct 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
5,500
$628.29K
16.1%
PCVX Vaxcyte, Inc.
3 Sep 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$186.88K
5.1%
PCVX Vaxcyte, Inc.
1 Aug 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$131.45K
5.1%
PCVX Vaxcyte, Inc.
1 Jul 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$127.30K
5.1%
PCVX Vaxcyte, Inc.
3 Jun 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$120.13K
5.1%
PCVX Vaxcyte, Inc.
1 May 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$102.92K
5.2%
PCVX Vaxcyte, Inc.
1 Apr 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$111.23K
5.2%
PCVX Vaxcyte, Inc.
1 Mar 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$122.91K
5.1%
PCVX Vaxcyte, Inc.
1 Feb 2024
SVP, GEN COUNSEL & CORP SEC
Sold on a plan
1,667
$123.14K
7.4%
PCVX Vaxcyte, Inc.
2 Jan 2024
SVP, Gen Counsel & Corp Sec
Sold on a plan
1,667
$106.58K
7.4%
PCVX Vaxcyte, Inc.
7 Dec 2023
SVP, Gen Counsel & Corp Sec
Sold on a plan
10,000
$565.00K
32.2%
PCVX Vaxcyte, Inc.
2 Oct 2023
SVP, Gen Counsel & Corp Sec
Sold on a plan
20,000
$1.01M
49.4%
18 decisions on file.